Drugs / TAK-667
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04654351 | Jan → Jul 2021 | hereditary angioedema | Takeda | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-667 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04654351 ↗ |
| Route | Subcutaneous | “Participants will take TAK-667 with SC administration on the abdomen.” NCT04654351 ↗ |